Montalbano, John

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Montalbano, John's trades of Eupraxia Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-24 2025-09-24 B Purchase
39,414 -12.2%
455.78
US$1,302,588
39,414 -12.2% 455.78 US$1,302,588
2023-08-20 2023-08-18 B Purchase
8,321 +19.6%
213.71
CA$4,464,789
8,321 +19.6% 213.71 CA$4,464,789
2022-09-07 2022-09-07 B Purchase
37,129 +48.7%
322.14
CA$2,623,009
37,129 +48.7% 322.14 CA$2,623,009
2022-09-07 2022-09-06 B Purchase
1,600 +0.1%
1.50
CA$2,400
1,600 +0.1% 1.50 CA$2,400